Heart diseases, particularly those caused by ischemia, are a leading cause of morbidity and mortality worldwide. Traditional treatment strategies often fall short in specificity and efficiency, necessitating a more targeted approach. RNAi therapy, which involves silencing specific genes responsible for disease pathology, presents a promising...
In the ever-evolving field of microfluidics, the integration of innovative technologies continues to redefine the boundaries of what is achievable. One of the most recent breakthroughs, as detailed in a research article published in Nature Communications, unveils the successful navigation of ultrasound-activated microrobots within...
Drug delivery systems aim at the controlled release and targeted delivery of pharmaceutical compounds to the body. With the advances made in miniaturized devices and microfluidic flow control systems, we are steps closer to fully automated microfluidic drug delivery systems with real-time monitoring capabilities. For...
Microfluidic devices have shown to have solutions for providing a means for controlled release and targeted delivery of drugs. For this week's research highlight, we have selected one such microfluidic advancement. In this recent paper published in Nature Communications a droplet microfluidic chip was employed...
Being one of the most promising areas of microfluidics, droplet microfluidics has been widely used for high-throughput data acquisition in the past decade. However, the potential of droplet microfluidic devices for generating products (therapeutics, cosmetics, etc.) with real-life applications has not yet been fully explored....